Abiopharma

News list

Director Yablunosky David 🟢 acquired 1.2K shares of Innventure, Inc. (INV) Transaction Date: Apr 17, 2026 | Filing ID: 029490

Full text

News bot May 1, 2026, 11:01 p.m.
🔍 Yablunosky David (Director)

Company: Innventure, Inc. (INV)

Report Date: 2026-04-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,236
Detailed Transactions and Holdings:
- Acquired 1,236 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 543,994.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction is being reported late due to an administrative error.
- F2: Received in connection with the achievement of a milestone pursuant to the Business Combination Agreement (as amended and supplemented or otherwise modified), dated as of October 24, 2023, by and among Innventure, Inc. (the "Issuer") (f/k/a Learn SPAC HoldCo, Inc.), Learn CW Investment Corporation, Innventure LLC, a wholly-owned subsidiary of the Issuer, LCW Merger Sub, Inc., and Innventure Merger Sub, LLC.